Penney Angela, Ng Camille, Sands Nathaniel, Gaikwad Ritu, Akhter Mutaal
College of Medicine, California Northstate University, Elk Grove, USA.
Department of Internal Medicine, Mercy General Hospital, Sacramento, USA.
Cureus. 2024 Sep 7;16(9):e68900. doi: 10.7759/cureus.68900. eCollection 2024 Sep.
Pseudomonas mendocina, a Gram-negative, aerobic bacillus, has rarely been implicated in human infections. This report details the first documented case of catheter-associated urinary tract infection (CAUTI) caused by P. mendocina in a COVID-19-positive patient. We present the case of a 70-year-old male with obstructive uropathy who presented with altered mental status eight days after testing positive for COVID-19. Urine cultures identified P. mendocina and Enterococcus faecalis. The antibiotic regimen was adjusted to cefepime and fosfomycin for coverage against P. mendocina and E. faecalis, respectively, resulting in the patient's improvement and discharge with an outpatient course of ciprofloxacin. However, the patient was readmitted 12 days later for recurrent symptoms and traumatic catheter removal, requiring nephrostomy tube placement. Follow-up revealed severe bladder and prostate abnormalities, confirming a complex interplay of factors contributing to his infection. P. mendocina is a rare opportunistic pathogen, often occurring in patients with pre-existing health conditions. This case is significant as the first CAUTI caused by P. mendocina and highlights potential links between COVID-19 and increased susceptibility to bacterial infections. The patient's comorbidities, particularly obstructive uropathy, and prolonged catheter use, were likely major factors in his infection. The role of COVID-19 in facilitating bacterial colonization remains speculative but warrants further investigation. This case report underscores the need for heightened clinical awareness and prompt intervention in patients with similar risk factors. The successful treatment regimen provides a valuable reference for managing such infections. Further research is needed to explore the interplay between viral and bacterial infections, particularly in the context of COVID-19.
门多萨假单胞菌是一种革兰氏阴性需氧杆菌,很少引起人类感染。本报告详细记录了首例由门多萨假单胞菌引起的新冠病毒检测呈阳性患者的导管相关性尿路感染(CAUTI)病例。我们报告了一名70岁男性梗阻性尿路病患者,在新冠病毒检测呈阳性8天后出现精神状态改变。尿培养鉴定出了门多萨假单胞菌和粪肠球菌。抗生素治疗方案调整为头孢吡肟和磷霉素,分别用于覆盖门多萨假单胞菌和粪肠球菌,患者病情好转并出院,门诊继续服用环丙沙星。然而,患者在12天后因症状复发和导尿管拔除创伤再次入院,需要放置肾造瘘管。随访发现膀胱和前列腺严重异常,证实多种因素之间存在复杂的相互作用导致了他的感染。门多萨假单胞菌是一种罕见的机会性病原体,常见于已有健康问题的患者。该病例作为首例由门多萨假单胞菌引起的CAUTI具有重要意义,突出了新冠病毒与细菌感染易感性增加之间的潜在联系。患者的合并症,特别是梗阻性尿路病和导尿管长期使用,可能是其感染的主要因素。新冠病毒在促进细菌定植中的作用仍具有推测性,但值得进一步研究。本病例报告强调了对具有类似危险因素患者提高临床认识和及时干预的必要性。成功的治疗方案为管理此类感染提供了有价值的参考。需要进一步研究以探索病毒和细菌感染之间的相互作用,特别是在新冠病毒背景下。